Acute Intermittent Hypoxia (AIH)
Acute Intermittent Hypoxia (AIH) is an intervention with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Assessing Upper Extremity Function in Chronic Stroke Survivors Through Acute Intermittent Hypoxia
Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury
BioFLO for Respiratory Recovery in SCI
Examining the Effect of Acute Intermittent Hypoxia on Serum Blood Proteins and Lower Limb Function
American Heart Association- Stroke/Hypoxia Study
Clinical Trials (7)
Assessing Upper Extremity Function in Chronic Stroke Survivors Through Acute Intermittent Hypoxia
Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury
BioFLO for Respiratory Recovery in SCI
Examining the Effect of Acute Intermittent Hypoxia on Serum Blood Proteins and Lower Limb Function
American Heart Association- Stroke/Hypoxia Study
Daily Intermittent Hypoxia and Task-Specific Upper Limb Training in Persons With Chronic Incomplete SCI
Study Effects of Intermittent Hypoxia on Restoring Hand Function Following SCI
All 7 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 7